IRX2-DT and urinary bladder neoplasm: Statistical analysis and fold change analysis identified nine top-ranking hypermethylated candidate genes (CDX2, CEI, DMC1, IMP-1, PDE3A, PENK, SIM2, VSX1, and ZNF312) in primary bladder tumors.